Literature DB >> 16940833

Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than 5 years of age for prevention of pneumonia: updated analysis using World Health Organization standardized interpretation of chest radiographs.

John Hansen1, Steven Black, Henry Shinefield, Thomas Cherian, Jane Benson, Bruce Fireman, Edwin Lewis, Paula Ray, Janelle Lee.   

Abstract

BACKGROUND: A World Health Organization (WHO) working group in 2001 developed a method for standardizing interpretation of chest radiographs in children for epidemiologic purposes. We reevaluated radiographs from the Kaiser Permanente Pneumococcal Efficacy trial using this method.
METHODS: Seven-valent pneumococcal conjugate vaccine was evaluated in a randomized, controlled study including 37,868 infants. Effectiveness against pneumonia was previously evaluated using the original treating radiologist reading. There were 2841 sets of radiographs from this trial and all available radiographs were scanned and read blindly by 2 WHO crosstrained readers (A and B); discordance between the 2 primary readers was resolved through a consensus reading by an adjudicating panel of 2 radiologists.
RESULTS: Of the 2841 radiographs, 2446 were available for scanning and were reviewed using WHO-defined descriptive categories. Two hundred fifty of the 2446 radiographs were read as positive by both readers. An additional 129 were read as positive by reader A only and 142 by reader B only for a total of 521 radiographs that were read as positive by one or both of the reviewers. The concordance rate between the 2 reviewers was 250 of 521 (48%). Of the 271 discordant radiographs, 45 of 129 (34.9%) of reader A and 66 of 142 (46.5%) for reader B were finalized as positive by the adjudicating panel. Overall, 361 radiographs were finalized as positive (12.7%). With these 361 images as the standard, the sensitivity and specificity of reader A were 82% and 97%, respectively, and for reader B, 88% and 97%, respectively. Kappa between the 2 readers was 0.58. Of 25 control radiographs read as positive by both A and B, 80% were also read as positive by the panel and all 25 control negative radiographs were read as negative by the panel. Using original readings by point-of-care radiologists, efficacy against first episode of radiograph confirmed pneumonia was 17.7% (95% confidence interval [CI] = 4.8-28.9%) in intent-to-treat and 20.5% (95% CI = 4.4-34%) in per protocol. Using the WHO method, the efficacy against first episode of radiograph confirmed pneumonia adjusting for age, gender and year of vaccination of 25.5% (95% CI = 6.5-40.7%, P = 0.011) for intent-to-treat and 30.3% (95% CI = 10.7-45.7%, P = 0.0043) for per protocol.
CONCLUSION: Using WHO criteria for reading of radiographs increased point estimates of vaccine efficacy presumably as a result of improved specificity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16940833     DOI: 10.1097/01.inf.0000232706.35674.2f

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  78 in total

1.  Newborn vitamin A supplementation does not affect nasopharyngeal carriage of Streptococcus pneumoniae in Bangladeshi infants at age 3 months.

Authors:  Christian L Coles; Alain Labrique; Samir K Saha; Hasmot Ali; Hassan Al-Emran; Mahbubur Rashid; Parul Christian; Keith P West; Rolf Klemm
Journal:  J Nutr       Date:  2011-08-10       Impact factor: 4.798

2.  Hospitalizations for lower respiratory tract infections in children in relation to the sequential use of three pneumococcal vaccines in Quebec.

Authors:  Zhou Zhou; Rodica Gilca; Geneviève Deceuninck; François Boucher; Philippe De Wals
Journal:  Can J Public Health       Date:  2020-06-11

3.  Deletion of arcD in Streptococcus pneumoniae D39 impairs its capsule and attenuates virulence.

Authors:  Radha Gupta; Jun Yang; Yimin Dong; Edwin Swiatlo; Jing-Ren Zhang; Dennis W Metzger; Guangchun Bai
Journal:  Infect Immun       Date:  2013-08-05       Impact factor: 3.441

4.  Estimating influenza-associated deaths in the United States.

Authors:  William W Thompson; Matthew R Moore; Eric Weintraub; Po-Yung Cheng; Xiaoping Jin; Carolyn B Bridges; Joseph S Bresee; David K Shay
Journal:  Am J Public Health       Date:  2009-10       Impact factor: 9.308

5.  Modeling the cost-effectiveness of infant vaccination with pneumococcal conjugate vaccines in Germany.

Authors:  Alexander Kuhlmann; J-Matthias Graf von der Schulenburg
Journal:  Eur J Health Econ       Date:  2016-02-23

6.  Cost-effectiveness evaluation of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine for children in Taiwan.

Authors:  Chun-Yi Lu; Ching-Hu Chung; Li-Min Huang; Eliza Kruger; Seng-Chuen Tan; Xu-Hao Zhang; Nan-Chang Chiu
Journal:  Cost Eff Resour Alloc       Date:  2020-08-28

7.  Improving Assessments of Population-level Vaccine Impact.

Authors:  Christian A W Bruhn; Cynthia Schuck-Paim; Esra Kürüm; Robert J Taylor; Lone Simonsen; Daniel M Weinberger
Journal:  Epidemiology       Date:  2017-03       Impact factor: 4.822

Review 8.  Use of vaccines as probes to define disease burden.

Authors:  Daniel R Feikin; J Anthony G Scott; Bradford D Gessner
Journal:  Lancet       Date:  2014-02-17       Impact factor: 79.321

9.  Modeling of cost effectiveness of pneumococcal conjugate vaccination strategies in U.S. older adults.

Authors:  Kenneth J Smith; Angela R Wateska; Mary Patricia Nowalk; Mahlon Raymund; Bruce Y Lee; Richard K Zimmerman
Journal:  Am J Prev Med       Date:  2013-04       Impact factor: 5.043

10.  Public health and economic impact of vaccination with 7-valent pneumococcal vaccine (PCV7) in the context of the annual influenza epidemic and a severe influenza pandemic.

Authors:  Jaime L Rubin; Lisa J McGarry; Keith P Klugman; David R Strutton; Kristen E Gilmore; Milton C Weinstein
Journal:  BMC Infect Dis       Date:  2010-01-21       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.